Latest Breaking News On - Advanced hematologic malignancies - Page 1 : vimarsana.com

The expert panel shares emerging data on an engineered, allogeneic cell-based therapy administered as part of conditioning for allo-HSCT in patients with relapsed, refractory, or high-risk hematologic cancers.

Optimizing outcomesAllogeneic transplantsAdvanced hematologicHematologic malignanciesHematologic cancersAllo hsctAllogeneic transplantAllo transplantHigh riskAdvanced hematologic malignanciesInvestigational allo hsct